Results 41 to 50 of about 2,055 (161)

Skim through medinfo: Information from the medinfo weblog (September-December 2007) [PDF]

, 2007
Are you up to date? This article provides a selection of the most interesting contents of the weblog medinfo from September to December 2007.Sind Sie auf dem Laufenden? Dieser Beitrag enthält eine Auswahl der interessantesten Inhalte aus dem medinfo-Blog
Klein, D
core  

IMIA WG LaMB event: 'Biomedical Semantics in the Big Data Era', Workshop at MEDINFO 2015 – São Paulo,Brazil [PDF]

, 2019
The workshop of IMIA WG 'Language and Meaning in Biomedicine' was held at MEDINFO 2015 – São Paulo,Brazil. This document has all the presentation materials: - Introduction, by Ronald Cornet - From free text to ontology, by Stephane Meystre - Bridging ...
Schulz, Stefan, Meystre, Stephane, Meystre, Stephane (8174370), Balkanyi, Laszlo, Adamusiak, Tomasz (8174376), Adamusiak, Tomasz, Cornet, Roland (8174367), Hu, Jianying, Ruch, Patrick, Schulz, Stefan (8174373), Balkanyi, Laszlo (8172993), Ruch, Patrick (5189168), Hu, Jianying (8174379), Cornet, Roland   +13 more
core   +1 more source

Personalizing Situated Workflows for Pervasive Healthcare Applications [PDF]

, 2008
In this paper, we present an approach where a workflow system is combined with a policy-based framework for the specification and enforcement of policies for healthcare applications.
Giovanni Russello, Dong, Changyu, Changyu Dong, Naranker Dulay, Russello, Giovanni, Dulay, Naranker   +5 more
core   +1 more source

Defining Renal Recovery in Patients With Hepatorenal Syndrome‐Acute Kidney Injury: Experience From North American Studies

JGH Open, Volume 8, Issue 12, December 2024.
ABSTRACT Introduction The degree of improvement in serum creatinine (SCr) has previously been suggested as a sensitive indicator of treatment response in patients with hepatorenal syndrome‐acute kidney injury (HRS‐AKI), while HRS reversal remains the primary endpoint in clinical trials.
Muhammad A. Mujtaba, Hussien Elsiesy, Sara Faiz, Syed A. Hussain, Ann Kathleen N. Gamilla‐Crudo, Aftab Karim, Mohammad Irfan Khan, Muhammad Waqar Khattak, Zunaira Zafar, Michael Kueht, Khurram Jamil   +10 more
wiley   +1 more source

B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity

Annals of Clinical and Translational Neurology, Volume 11, Issue 10, Page 2792-2798, October 2024.
Abstract This post hoc analysis of the randomized, placebo‐controlled N‐MOmentum study (NCT02200770) of inebilizumab in neuromyelitis optica spectrum disorder (NMOSD) evaluated relationships between circulating B‐cell subsets and aquaporin‐4 immunoglobulin G (AQP4‐lgG) titers and attacks.
Jeffrey L. Bennett, Sean J. Pittock, Friedemann Paul, Ho Jin Kim, Sarosh R. Irani, Kevin C. O'Connor, Kristina R. Patterson, Michael A. Smith, Michele Gunsior, Nanette Mittereder, William A. Rees, Daniel Cimbora, Bruce A. C. Cree   +12 more
wiley   +1 more source

Development of a virtual reality system for early mobilization of critically ill patients [PDF]

17th World Congress on Medical and Health Informatics, MEDINFO 2019, 25-30 August 2019, Lyon, France202312 bckwVersion of RecordSelf ...
Wang, J, Xiao, Q, Zhang, C, Shi, C, Choi, T, Jia, Y   +5 more
core   +1 more source

Comparative analysis of real‐world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims study

Neurourology and Urodynamics, Volume 43, Issue 7, Page 1504-1513, September 2024.
Abstract Introduction Vibegron is a selective β3‐adrenergic receptor agonist that was approved by the US Food and Drug Administration in December 2020 for the treatment of overactive bladder in adults. This retrospective study assessed US pharmacy claims data to evaluate the real‐world adherence and persistence of vibegron compared with mirabegron and ...
Benjamin Chastek, Adam Carrera, Christina Landis, Daniel Snyder, Laleh Abedinzadeh, Tim Bancroft, Jeffrey Nesheim, Michael Kennelly, David Staskin   +8 more
wiley   +1 more source

Adatbázis-ajánló, Szolgáltatási lehetőségek a MEDINFO adatbázisaiból [PDF]

, 2018
This review presents uses of the forty databases available from MEDINFO directly and through MEDINFO as gateway, with special focus on International Digest of Health Legislation, WHO, KABIT and ADONIS databases.Az 1989-90-ben elindult társadalmi ...
Jehoda, Imola, Latin, Györgyi, Percze, Lajosné   +2 more
core  

Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 study

Cancer, Volume 130, Issue 16, Page 2812-2821, 15 August 2024.
Abstract Introduction Nirogacestat is a targeted gamma secretase inhibitor approved in the United States for adults with progressing desmoid tumors. In the phase 3 DeFi study (NCT03785964) of nirogacestat, ovarian toxicity (OT) was identified as a safety signal among females of reproductive potential (FORP).
Elizabeth T. Loggers, Rashmi Chugh, Noah Federman, Lee Hartner, Richard F. Riedel, Sunny Cho, David Hyslop, Allison Lim, Ana B. Oton, Kutluk H. Oktay   +9 more
wiley   +1 more source

Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons

Gut and Liver
Ascites is the most common complication in patients with decompensated cirrhosis. This condition results in a severely impaired quality of life, excessive healthcare use, recurrent hospitalizations and significant morbidity and mortality.
Yuan Gao, Xin Liu, Yunyi Gao, Meili Duan, Bing Hou, Yu Chen   +5 more
doaj   +1 more source